top of page
Reveles Webiste.png



Clinical Trials

Pioneering Representation in Discovery

Reveles Webiste (9)_edited.png


Creating a world where knowledge is accessible, understanding is shared, and the power of science is embraced. Together, we can unlock a future full of possibility and hope.


The math isn't mathing.


By the year 2030, the population of BIPOC communities in the United States is projected to represent 44.24 percent.


84 percent of people of color make up the worldwide majority, while caucasian communities only account for 16 percent.

80% - 90%

However, a large majority of those taking part in clinical trials for new medications are disproportionately Caucasian - sometimes as much as 80 to 90 percent.


four pillars reveles (3).png
four pillars reveles.png
four pillars reveles (1).png
four pillars reveles (2).png
Woman Portrait_edited.png
Untitled design (5)_edited.png

We are dedicated to forming trusted relationships with BIPOC communities, hinging on four core areas: representation, research, education, and engagement.


We acknowledge the impact of cultural values on the decisions made by people of color in individual, communal, and international contexts.


We are set on creating a system of interaction based on this knowledge and understand that Black, Indigenous, Latinx, and Asian individuals have faith in their own communities.

R'Kes Starling, Founder & CEO

When my Mom was diagnosed with an unusual lung condition, we started researching potential treatments. We discovered a trial available for her, but it was too far away for her to participate. Seeing my mother's disappointment was a pivotal moment for me. I was a high-ranking executive in the healthcare sector for McKesson, responsible for over 300M in business, and I was still unable to help her. Fortunately, she overcame her illness, which inspired me to create Reveles to ensure that underserved populations can be a part of finding cures for current and future generations.

  • LinkedIn


Untitled design (7).png


70% of potential participants live more than 2 hours away from their nearest study center which limits recruitment and retention. (1)


Out of 40,000 clinical trials recruiting in the US, 80% were delayed due to recruitment challenges. (2)


85% of clinical trials fail to retain enough patients. (3) 


Across all clinical trials the average drop-out rate is 30%, when more than 12,000 people. (4)


More than 75% responded that collecting all data on their own at home or having nurses come to their home for all study visits were appealing choices (3)

bottom of page